Hudson Bay Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Hudson Bay Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.33M	Sell	77,500 -92,500	-54%	-$3.06M	0.01%	731
2025 Q4	$5.56M	Sell	170,000 -75,000	-31%	-$2.42M	0.02%	475
2025 Q3	$8.49M	Sell	245,000 -270,000	-52%	-$8.64M	0.03%	399
2025 Q2	$14.4M	Sell	515,000 -50,000	-9%	-$1.34M	0.05%	274
2025 Q1	$14.2M	Buy	565,000 +10,700	+2%	+$270K	0.04%	322
2024 Q4	$15.2M	Buy	554,300 +44,300	+9%	+$1.23M	0.05%	280
2024 Q3	$14.7M	Sell	510,000 -15,000	-3%	-$408K	0.06%	212
2024 Q2	$13M	Buy	525,000 +92,600	+21%	+$2.63M	0.06%	190
2024 Q1	$13.9M	Buy	432,400 +100,400	+30%	+$3.73M	0.08%	142
2023 Q4	$13.5M	Sell	332,000 -18,000	-5%	-$662K	0.09%	141
2023 Q3	$12.1M	Buy	350,000 +25,000	+8%	+$973K	0.1%	140
2023 Q2	$13.2M	Sell	325,000 -7,500	-2%	-$306K	0.1%	141
2023 Q1	$12.8M	Buy	332,500 +20,000	+6%	+$822K	0.11%	141
2022 Q4	$13.9M	Sell	312,500 -10,000	-3%	-$421K	0.14%	125
2022 Q3	$13.8M	Buy	322,500 +106,000	+49%	+$5.43M	0.12%	113
2022 Q2	$12.1M	Buy	216,500 +184,000	+566%	+$10.9M	0.09%	147
2022 Q1	$2.02M	Sell	32,500 -112,500	-78%	-$6.89M	0.03%	688
2021 Q4	$7.99M	Sell	145,000 -10,000	-6%	-$522K	0.08%	188
2021 Q3	$8.15M	Buy	155,000 +30,000	+24%	+$1.78M	0.11%	186
2021 Q2	$8.61M	Buy	125,000 +67,500	+117%	+$5.15M	0.1%	171
2021 Q1	$4.43M	Buy	+57,500	New	+$5.3M	0.05%	333
2018 Q2	–	Sell	-13,700	Closed	-$1.37M	–	868
2018 Q1	$1.37M	Buy	+13,700	New	+$1.48M	0.03%	521
2017 Q3	–	Sell	-20,000	Closed	-$1.53M	–	443
2017 Q2	$1.53M	Buy	+20,000	New	+$1.68M	0.03%	376

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hudson Bay Capital Management's LKFT Position: Q1 2026 in Review

Hudson Bay Capital Management reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 54% in Q1 2026, selling an estimated $3.06M and leaving 77,500 shares worth $2.33M. The position accounts for 0.01% of the portfolio, ranked #731.

Hudson Bay Capital Management first reported a position in LKFT in Q2 2017 and has held it in 23 quarters since. The position peaked at $15.2M in Q4 2024. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

Hudson Bay Capital Management held 77,500 shares of Lakefront Biotherapeutics American Depositary Shares worth $2.33M as of Q1 2026.
Hudson Bay Capital Management sold 92,500 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $3.06M.
Lakefront Biotherapeutics American Depositary Shares made up 0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #731 holding.
Hudson Bay Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2017 and has held it in 23 quarters since.
Hudson Bay Capital Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $15.2M in Q4 2024.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.